FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W973230690> ?p ?o ?g. }

• W973230690 abstract "Background : Hormone receptor (Estrogen receptor (ER), Progesterone receptor (PgR)) is an important biological marker for predicting prognosis and making effective treatment decisions. Discordance in these biomarkers between the primary tumor and recurrent lesions is reported frequently. However, it is not well known whether these biomarkers are affected by neoadjuvant chemotherapy and their impacts on outcomes still remain to be elucidated. The aim of the present study is to evaluate the changes in HR status after neoadjuvant chemotherapy in patients with operable breast cancer and their relationship with response to treatment and prognosis. Patients and Methods : Of 162 patients with stage II/III breast cancer patients receiving neoadjuvant chemotherapy from January 2005 to September 2012 at Keio University Hospital, 140 patients with non-pCR were analyzed. Patients were treated with sequential anthracycline and taxane. ER and PgR were assessed in both CNB performed prior to neoadjuvant chemotherapy and surgical samples. HR status was assessed by immunohistochemistry (IHC). ER/PgR status was determined using the Allred score and defined as positive when score was 3 and more. HR status was considered positive in cases of ER and/or PgR positivity. Pathological response criteria were classified as grade 0, 1, 2, or 3: grade 0 includes almost no change in cancer cells; grade 1 includes slight or marked changes in less than two thirds of area; grade 2 includes marked changes in more than two thirds of area; grade3 includes necrosis or disappearance of all tumor cells. Results : ER, PgR and HR positive rates before neoadjuvant chemotherapy were 72.9%, 67.1% and 76.4%, respectively. Changes in ER, PgR and HR status between CNB and surgical samples were 12.1% (4.3% gain; 7.8% loss), 17.1% (2.1% gain; 15.0% loss) and 9.3% (2.9% gain; 6.4% loss), respectively. In ER-discordant group, grade 2 rate of pathological response was significantly higher than ER- concordant group (61.1% vs. 30%, p=0.033), whereas there were no significant differences of pathological response between discordant and concordant group in PgR status. In the disease free survival (DFS), there were no significant difference between concordance and discordance group for ER, PgR and HR (p=0.216, 0.859, 0.233) after a median follow-up of 40.4 months. But patients with a loss in ER and/or HR status had a trend to a shorter DFS compared with the concordant ER and/or HR-positive group (p=0.169 and 0.154) Conclusions : After neoadjuvant chemotherapy, discordance of biomarkers was seen in 5-20%. The pathological response was significantly associated with the change in ER status. A loss in ER and/or HR status may affect a prognosis of breast cancer after neoadjuvant chemotherapy, but still need further investigation. Citation Format: Toshiaki Kurihara, Hanako Ueno, Masaru Takemae, Aiko Nagayama, Maiko Takahashi, Tetsu Hayashida, Hiromitsu Jinno, Yuko Kitagawa. Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P3-06-49." @default.
• W973230690 created "2016-06-24" @default.
• W973230690 creator A5006148872 @default.
• W973230690 creator A5018112691 @default.
• W973230690 creator A5036916962 @default.
• W973230690 creator A5049694850 @default.
• W973230690 creator A5057259711 @default.
• W973230690 creator A5062984141 @default.
• W973230690 creator A5065368640 @default.
• W973230690 creator A5067153821 @default.
• W973230690 date "2015-04-30" @default.
• W973230690 modified "2023-09-27" @default.
• W973230690 title "Abstract P3-06-49: Prognostic impact of discordance in hormone receptor status after the neoadjuvant chemotherapy in primary breast cancer" @default.
• W973230690 doi "https://doi.org/10.1158/1538-7445.sabcs14-p3-06-49" @default.
• W973230690 hasPublicationYear "2015" @default.
• W973230690 type Work @default.
• W973230690 sameAs 973230690 @default.
• W973230690 citedByCount "0" @default.
• W973230690 crossrefType "proceedings-article" @default.
• W973230690 hasAuthorship W973230690A5006148872 @default.
• W973230690 hasAuthorship W973230690A5018112691 @default.
• W973230690 hasAuthorship W973230690A5036916962 @default.
• W973230690 hasAuthorship W973230690A5049694850 @default.
• W973230690 hasAuthorship W973230690A5057259711 @default.
• W973230690 hasAuthorship W973230690A5062984141 @default.
• W973230690 hasAuthorship W973230690A5065368640 @default.
• W973230690 hasAuthorship W973230690A5067153821 @default.
• W973230690 hasConcept C121608353 @default.
• W973230690 hasConcept C126322002 @default.
• W973230690 hasConcept C143998085 @default.
• W973230690 hasConcept C146357865 @default.
• W973230690 hasConcept C151730666 @default.
• W973230690 hasConcept C204232928 @default.
• W973230690 hasConcept C207886595 @default.
• W973230690 hasConcept C23589133 @default.
• W973230690 hasConcept C2776694085 @default.
• W973230690 hasConcept C2776802502 @default.
• W973230690 hasConcept C2777511904 @default.
• W973230690 hasConcept C2778292576 @default.
• W973230690 hasConcept C2779013556 @default.
• W973230690 hasConcept C2780283643 @default.
• W973230690 hasConcept C530470458 @default.
• W973230690 hasConcept C71924100 @default.
• W973230690 hasConcept C84606932 @default.
• W973230690 hasConcept C86803240 @default.
• W973230690 hasConcept C98717036 @default.
• W973230690 hasConceptScore W973230690C121608353 @default.
• W973230690 hasConceptScore W973230690C126322002 @default.
• W973230690 hasConceptScore W973230690C143998085 @default.
• W973230690 hasConceptScore W973230690C146357865 @default.
• W973230690 hasConceptScore W973230690C151730666 @default.
• W973230690 hasConceptScore W973230690C204232928 @default.
• W973230690 hasConceptScore W973230690C207886595 @default.
• W973230690 hasConceptScore W973230690C23589133 @default.
• W973230690 hasConceptScore W973230690C2776694085 @default.
• W973230690 hasConceptScore W973230690C2776802502 @default.
• W973230690 hasConceptScore W973230690C2777511904 @default.
• W973230690 hasConceptScore W973230690C2778292576 @default.
• W973230690 hasConceptScore W973230690C2779013556 @default.
• W973230690 hasConceptScore W973230690C2780283643 @default.
• W973230690 hasConceptScore W973230690C530470458 @default.
• W973230690 hasConceptScore W973230690C71924100 @default.
• W973230690 hasConceptScore W973230690C84606932 @default.
• W973230690 hasConceptScore W973230690C86803240 @default.
• W973230690 hasConceptScore W973230690C98717036 @default.
• W973230690 hasLocation W9732306901 @default.
• W973230690 hasOpenAccess W973230690 @default.
• W973230690 hasPrimaryLocation W9732306901 @default.
• W973230690 hasRelatedWork W14333088 @default.
• W973230690 hasRelatedWork W14542699 @default.
• W973230690 hasRelatedWork W14561912 @default.
• W973230690 hasRelatedWork W15852517 @default.
• W973230690 hasRelatedWork W1852032 @default.
• W973230690 hasRelatedWork W18725558 @default.
• W973230690 hasRelatedWork W5038423 @default.
• W973230690 hasRelatedWork W7064336 @default.
• W973230690 hasRelatedWork W7729919 @default.
• W973230690 hasRelatedWork W9175836 @default.
• W973230690 isParatext "false" @default.
• W973230690 isRetracted "false" @default.
• W973230690 magId "973230690" @default.
• W973230690 workType "article" @default.